Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines

Makoto Kubo, Masayo Umebayashi, Kanako Kurata, Hitomi Mori, Masaya Kai, Hideya Onishi, Mitsuo Katano, Masafumi Nakamura, Takashi Morisaki

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Catumaxomab with activated T-cells efficiently lyses chemoresistant EpCAM-positive triple-negative breast cancer cell lines'. Together they form a unique fingerprint.

Medicine and Dentistry